In agreement, pharmacological increase of c-Fos does not worsen motor neuron death in SMA mice and accompanies neuroprotection in ALS (Baczyk et al., 2020; Simon et al., 2021). The gene discussed is FOS; the disease is amyotrophic lateral sclerosis.